Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 11, 2011

View Archived Issues

New heart valves challenge Edwards in transapical space

PARIS — Europe is back on the frontlines in the development of transcatheter aortic valve implantation (TAVI). (Medical Device Daily) Read More

Greater surgeon control key to new TAVI valves

Washington roundup: Parallel review pilot: just a new saddle on an old nag?

HIT seen as the hottest investment in healthcare

Financings roundup: Zeltiq seeks to raise $128M through IPO

HIT roundup: St. Jude launches new version of Merlin.net

Coming Wednesday in MDD Perspectives: A really bad idea: FDA conducting CE research

Agreements/contracts: Maquet Cardio to supply intra-aortic balloon pumps

Patent watch: Bovie gets electrosurgical leakage device approval

Med-Tech Notes

People in the News

Product Briefs

MDD's Cardio Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...